Hartford Investment Management Co. Sells 2,287 Shares of Kenvue Inc. (NYSE:KVUE)

Hartford Investment Management Co. decreased its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 118,220 shares of the company’s stock after selling 2,287 shares during the period. Hartford Investment Management Co.’s holdings in Kenvue were worth $2,524,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of KVUE. Focus Financial Network Inc. lifted its holdings in Kenvue by 10.5% during the 4th quarter. Focus Financial Network Inc. now owns 11,529 shares of the company’s stock valued at $246,000 after purchasing an additional 1,095 shares during the last quarter. Summit Trail Advisors LLC increased its holdings in shares of Kenvue by 60.4% during the fourth quarter. Summit Trail Advisors LLC now owns 17,651 shares of the company’s stock worth $377,000 after buying an additional 6,646 shares in the last quarter. Principle Wealth Partners LLC boosted its holdings in shares of Kenvue by 3.7% in the 4th quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company’s stock worth $303,000 after acquiring an additional 500 shares in the last quarter. Savant Capital LLC grew its position in Kenvue by 5.2% during the 4th quarter. Savant Capital LLC now owns 16,241 shares of the company’s stock worth $347,000 after acquiring an additional 798 shares during the last quarter. Finally, Angeles Wealth Management LLC acquired a new stake in Kenvue during the 4th quarter valued at $216,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on KVUE shares. Barclays cut their price target on Kenvue from $23.00 to $21.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Piper Sandler upgraded shares of Kenvue from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $21.00 to $26.00 in a research report on Monday, January 6th. UBS Group decreased their price target on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Canaccord Genuity Group dropped their price objective on shares of Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, February 7th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus target price of $23.00.

Kenvue Trading Up 0.2 %

Shares of KVUE stock opened at $20.96 on Thursday. The stock’s fifty day moving average price is $21.41 and its two-hundred day moving average price is $22.03. The company has a market cap of $40.19 billion, a PE ratio of 39.55, a P/E/G ratio of 2.16 and a beta of 1.45. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Equities analysts predict that Kenvue Inc. will post 1.05 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be paid a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.91%. The ex-dividend date is Wednesday, February 12th. Kenvue’s payout ratio is 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.